Attention deficit hyperactivity disorder (ADHD) therapeutics Market Emerging Growth by Top Players | Shire plc, Neos Therapeutics, Eli Lilly and Company, Pfizer, Alcobra Ltd, Supernus Pharmaceuticals, Noven Pharmaceuticals, Novartis AG, Johnson & Johnson

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview:

Attention Deficit Hyperactivity Disorder (ADHD) is a neural disorder. The disorder is characterized by impulsivity, hyperactivity and attention disorders. ADHD treatment involves a combination of counselling, medications, and lifestyle changes. ADHD is the most commonly diagnosed mental disorder in adults and children, and the exact cause is not identified in most cases. Researchers at the National Institute of Mental Health (NIMH) suggest that factors that affect mental illness include heredity, brain damage, low birth weight, drug use during pregnancy and exposure. Environmental toxins, such as lead at a young age. Currently available treatments such as medications, counselling, lifestyle changes or a combination of these treatments help reduce symptoms and improve patient function.

Request for Sample @ https://www.marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market-304/request-sample

Growth of attention deficit hyperactivity disorder (ADHD) therapeutics market is attributed to increasing advancements in the medical field, the growing number of researches in neurosciences, raising awareness about mental illness among people, and increasing focus of biotechnology & pharmaceutical companies to develop the innovative therapeutics for ADHD. However, the high cost of the ADHD medications, improper reimbursement policies, and side effects related to ADHD medications (such as insomnia, anorexia, dizziness, headaches, and mood changes) are restraining the growth of global attention deficit hyperactivity disorder therapeutics market.

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast Report (2018-2023):

Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market is estimated to reach $ 12.43 billion by 2020 from $ 8.08 billion in 2015 with a CAGR of 9.00%.

Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market-304/

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Segmentation:

Attention deficit hyperactivity disorder (ADHD) therapeutics market is segmented based on medication, psychotherapy, and education or training. Medication involves stimulants and non-stimulants. Medication by stimulants comprises of amphetamines, methylphenidate, dextroamphetamine, and dexmethylphenidate, whereas medication by non-stimulants comprises of atomoxetine, bupropion, and guanfacine. Psychotherapy involves behavior therapy, cognitive behavioral therapy, interpersonal psychotherapy, and family therapy. Education or training involves parent management training, social skills training, and school-based interventions.

Geographically, the Global Attention deficit hyperactivity disorder (ADHD) therapeutics market is differentiated over North America, Asia Pacific, Middle East and Africa, Europe and Latin America. North America accounted for the largest market share of 36.0% of global attention deficit hyperactivity disorder (ADHD) therapeutics market in 2018, owing to availability of good healthcare infrastructure, presence of ongoing clinical trials, early approval of therapeutics in the U.S., increasing number of learning disability patients, growing adoption for ADHD therapeutics, existence of insurance policies for brain monitoring technologies, and government support for the technological advancements in neurosciences. Asia-Pacific region is estimated to be the fastest growing segment with a CAGR of 12.30% during forecast period 2018-2023.

Buy now @ https://www.marketdataforecast.com/cart/buy-now/attention-deficit-hyperactivity-disorder-therapeutics-market-304/

Major Players:

The key players in global attention deficit hyperactivity disorder (ADHD) therapeutics market such as, Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.), and Curemark, LLC. (U.S.).

The scope of the report:

1. Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the untapped regions.
2. The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
3. Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
4. Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
5. Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
6. A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
7. Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
8. An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Customize Report @ https://www.marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market-304/customize-report

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com

This release was published on openPR.